Truist Securities initiated coverage on Integer Holdings Corporation (NYSE:ITGR), noting the company as one of the largest med device outsource manufacturers and a unique SMID MedTech asset.
The analyst notes Integer’s profitability and leveraged EPS growth prospects (1.5-2x that of revenue), which can sustain a high-teens 2023-2026 EPS CAGR.
Integer has increasing exposure (through the OEM supply chain) to growth segments & emerging product cycles across the MedTech sector, Truist writes.
Also, a durable inorganic (tuck-in) strategy can add at least 1-2%+ on top of a high-single-digit organic top-line, the analyst adds.
Truist initiates with a Buy rating and ...